Abstract
IntroductionIn 2019, the national center for pharmacoeconomics (NCPE) released a managed access protocol (MAP) for the prescribing of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in Ireland. To be eligible...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have